Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
Add more filters










Publication year range
1.
Leukemia ; 16(4): 700-7, 2002 Apr.
Article in English | MEDLINE | ID: mdl-11960352

ABSTRACT

The execution phase of apoptosis occurs through the activation and function of caspases which cleave key substrates that orchestrate the death process. Here, we have compared the sensitivity of various T and B cell lines to death receptor or staurosporine-induced apoptosis. First, we found a lack of correlation between death receptor expression and sensitivity to Fas or Trail. By contrast, a correlation between caspase activation, DNA fragmentation and cell death in T cell lines was evidenced. Among T cells, CEM underwent apoptosis in response to CH11 but were resistant to Trail in agreement with the absence of Trail receptors (DR4 and DR5) on their surface. The B cell line SKW 6.4 was sensitive to CH11 and staurosporine but resistant to Trail. As B cell lines expressed significant levels of DR4 and DR5, resistance to Trail in SKW 6.4 is likely due to the expression of the decoy receptor DcR1. Burkitt's lymphoma such as RPMI 8866 and Raji did not exhibit DNA fragmentation in response to CH11, Trail or staurosporine but showed long-term caspase-dependent loss of viability upon effector treatment. The B cell lines used in this study express very weak or undetectable levels of DFF40 and relatively high levels of DFF45. Interestingly, cytosolic extracts from RPMI 88.66 but not other B lymphoma exhibit altered levels of cytochrome c-dependent caspase activation. Taken together, our results show that: (1) death receptor expression does not correlate with sensitivity to apoptosis; (2) the very low ratio of DFF40 vs. DFF45 is unlikely to explain by itself the lack of DNA fragmentation observed in certain B cell lines; and (3) a defective cytochrome c-dependent caspase activation might account at least in part for the insensitivity of certain Burkitt's lymphoma (RPMI 88.66) to apoptosis. Thus it seems that resistance of Burkitt's lymphoma to apoptosis is not governed by a general mechanism, but is rather multifactorial and differs from one cell line to another.


Subject(s)
Apoptosis/drug effects , Burkitt Lymphoma/metabolism , Caspases/metabolism , Deoxyribonucleases/metabolism , Leukemia, B-Cell/metabolism , Leukemia, T-Cell/metabolism , Proteins/metabolism , Antineoplastic Agents/pharmacology , Apoptosis Regulatory Proteins , Apoptotic Protease-Activating Factor 1 , Blotting, Western , Burkitt Lymphoma/pathology , Cell Survival/drug effects , Cytochrome c Group/metabolism , DNA Fragmentation , DNA Primers/chemistry , DNA, Neoplasm/analysis , Dose-Response Relationship, Drug , Enzyme Activation , Enzyme Inhibitors/pharmacology , Flow Cytometry , Humans , Intracellular Signaling Peptides and Proteins , Leukemia, B-Cell/pathology , Leukemia, T-Cell/pathology , Membrane Glycoproteins/pharmacology , Poly-ADP-Ribose Binding Proteins , Reverse Transcriptase Polymerase Chain Reaction , Staurosporine/pharmacology , TNF-Related Apoptosis-Inducing Ligand , Tumor Cells, Cultured/drug effects , Tumor Cells, Cultured/metabolism , Tumor Necrosis Factor-alpha/pharmacology
2.
FASEB J ; 15(11): 2027-9, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11511513

ABSTRACT

Polymorphonuclear neutrophils (PMNs) are the major source of proteolytic activities involved mainly in tissue injuries observed in chronic inflammatory disorders. High levels of soluble forms of CD23 (the low-affinity receptor for IgE) were found in biological fluids from these patients, and recent reports focused on a CD23-mediated regulation of inflammatory response. In this context, we show here that co-culture of activated PMN with CD23+ B cells resulted in a drastic release of soluble CD23 fragments from the cell surface. This cleavage was inhibited by serine proteases inhibitors, including a1-antitrypsin. We next demonstrated that purified human leukocyte elastase or cathepsin G efficiently cleaved membrane CD23 on B cells with a high specificity. Soluble fragments released by serine proteases-mediated CD23 proteolysis stimulated resting monocytes to produce oxidative burst and proinflammatory cytokine without any co-stimulatory signal. This work strongly supports the idea that the capacity of PMN-derived proteases to release soluble forms of CD23 participates in the inflammatory process mediated by these cells.


Subject(s)
Cathepsins/metabolism , Leukocyte Elastase/metabolism , Neutrophils/enzymology , Receptors, IgE/metabolism , Animals , Cathepsin G , Cell Membrane/metabolism , Humans , Mice , Monocytes/metabolism , Neutrophil Activation , Serine Endopeptidases , Solubility
3.
FASEB J ; 13(2): 305-12, 1999 Feb.
Article in English | MEDLINE | ID: mdl-9973318

ABSTRACT

Several lines of evidence have supported a link betweeen adipose tissue and immunocompetent cells. This link is illustrated in obesity, where excess adiposity and impaired immune function have been described in both humans and genetically obese rodents. In addition, numerous factors involved in inflammatory response are secreted by both preadipocytes and macrophages. Here we show that proliferating preadipocytes in cell lines and primary cultures, develop phagocytic activity toward microorganisms. This is demonstrated by phagocytosis assays and confocal microscopy. This function disappears when preadipocytes stop proliferating and differentiate into adipocytes. After phagocytosis, preadipocytes show microbicide activity via an oxygen-dependent mechanism. In addition, preadipocytes as well as adipocytes are stained with MOMA-2, a marker of monocyte-macrophage lineage, but are negative for specific mature macrophage markers (F4/80 and Mac-1). These results suggest that preadipocytes could function as macrophage-like cells and raise the possibility of a potential direct involvement of adipose tissue in inflammatory processes.


Subject(s)
Adipocytes/cytology , Adipocytes/immunology , Macrophages/cytology , Animals , Cell Differentiation/immunology , Cell Line , Cell Lineage , Female , Macrophages/immunology , Mice , Phagocytosis/immunology , Rats , Rats, Wistar
4.
J Biol Chem ; 273(48): 31795-800, 1998 Nov 27.
Article in English | MEDLINE | ID: mdl-9822645

ABSTRACT

In the present study we have compared the binding of two monoclonal antibodies to CD23, EBVCS1 and mAb25, which recognize the stalk and the lectin domain, respectively, on the CD23 molecule. At 4 degreesC, EBVCS1 binds to about 10% of the receptors recognized by mAb25 on the B cell surface. At 37 degreesC, whereas mAb25 reaches its maximal binding within a few seconds, EBVCS1 requires 60 min to bind to the same extent. Stabilization of the oligomeric structure of CD23 with IgE strongly affects in a dose-dependent fashion the number of binding sites seen by EBVCS1 but not the t1/2 to reach them, suggesting that EBVCS1 binds to the coiled coil region through an allosteric mechanism. EBVCS1 rapidly down-modulates the membrane CD23 expression with a coincident increase of CD23-soluble fragments in the culture medium, an effect that is inhibited by IgE. In contrast, mAb25, as well as IgE, protects CD23 from proteolytic cleavage and stimulates its endocytosis. These results suggest that EBVCS1 unravels the coiled coil structure of CD23, rendering it more susceptible to proteolytic attack. This supports the oligomeric model proposed previously (Gould, H., Sutton, B., Edmeades, R., and Beavil, A. (1991) Monogr. Allergy 29, 28-49). The biological significance of these observations is discussed.


Subject(s)
Antibodies, Monoclonal , B-Lymphocytes/immunology , Receptors, IgE/metabolism , Allosteric Regulation , Binding Sites, Antibody , Cell Line , Cell Membrane/immunology , Endocytosis , Gene Expression Regulation , Humans , Kinetics , Lectins , Leucine Zippers , Macromolecular Substances , Receptors, IgE/chemistry , Receptors, IgE/genetics , Receptors, IgE/immunology
5.
Eur J Immunol ; 25(7): 1872-6, 1995 Jul.
Article in English | MEDLINE | ID: mdl-7542593

ABSTRACT

CD20 monoclonal antibody (mAb) B1 is known to inhibit B cell proliferation. We show that B1 reduced both anti-mu + interleukin-4 (IL-4)-induced DNA synthesis and the concomitant expression of CD23 at the surface of human tonsillar B cells. B1 mAb had no effect on CD23 mRNA levels. The disappearance of CD23 molecule from the surface correlates with an increase of soluble CD23 fragments in the culture medium, indicating that CD20 mAb B1 stimulated the cleavage of the molecule. B1 also inhibits IgE production by peripheral blood mononuclear cells cultured in the presence of IL-4. Suppression of IgE synthesis and enhancement of CD23 cleavage are concomitant but appear not to be functionally related.


Subject(s)
Antigens, CD/immunology , Antigens, Differentiation, B-Lymphocyte/immunology , B-Lymphocytes/immunology , Interleukin-4/pharmacology , Receptors, IgE/metabolism , Antibodies, Monoclonal , Antibody Formation/drug effects , Antigens, CD20 , Cell Membrane/metabolism , Child , Gene Expression/drug effects , Humans , In Vitro Techniques , RNA, Messenger/genetics
6.
J Biol Chem ; 269(9): 6927-30, 1994 Mar 04.
Article in English | MEDLINE | ID: mdl-7509812

ABSTRACT

This study demonstrates that monoclonal antibodies to the B cell-specific CD20 molecule down-regulate both constitutive and interleukin-4-induced CD23 expression on Epstein-Barr-transformed B cells. This effect of CD20 antibody B1 does not take place at the transcriptional level as shown by the lack of effect on the CD23 mRNA level. Incorporation of 35S-labeled amino acids into CD23 polypeptide chain is not affected either. In cycloheximide-treated cells, B1 increases the decline of CD23 from the cell surface. The disappearance of CD23 molecule correlates with an increase of soluble CD23 fragments detected in the culture medium. Taken collectively, these results indicate that CD20 mAb B1 stimulates the cleavage of the CD23 molecule at the surface of B cells.


Subject(s)
Antibodies, Monoclonal/pharmacology , Antigens, CD/physiology , Antigens, Differentiation, B-Lymphocyte/physiology , B-Lymphocytes/immunology , Herpesvirus 4, Human/genetics , Receptors, IgE/metabolism , Antigens, CD/biosynthesis , Antigens, CD/immunology , Antigens, CD20 , Antigens, Differentiation, B-Lymphocyte/immunology , B-Lymphocytes/drug effects , B-Lymphocytes/metabolism , Blotting, Northern , Cell Line, Transformed , Cycloheximide/pharmacology , Down-Regulation , Humans , Interleukin-4/pharmacology , Kinetics , RNA, Messenger/metabolism , Receptors, IgE/biosynthesis
7.
Cell Immunol ; 152(1): 143-51, 1993 Nov.
Article in English | MEDLINE | ID: mdl-8242757

ABSTRACT

In T cells CD3 monoclonal antibodies mediate an elevation of cytosolic Ca2+ concentration due to a release from internal stores and also due to an entry from extracellular medium, the mechanism of which is not clearly elucidated. Previous studies on several cell types have reported that depleting intracellular Ca2+ stores with inhibitors of the reticulum Ca(2+)-ATPase resulted in an increased plasma membrane permeability to calcium ions. It has been suggested that emptying the reticulum triggers a Ca2+ influx from extracellular medium, independent of phosphoinositide hydrolysis. To document the physiological relevance of such a mechanism, we compared CD3- and thapsigargin-induced sustained increase of cytosolic Ca2+ concentration in Jurkat T cells with regard to their sensitivity to internal and external Ca2+ level and to several inhibitors which do not affect the release of internal stores. We show that (1) there was no additivity of the two effects; (2) both CD3- and thapsigargin-evoked Ca2+ influx were inhibited when membrane was depolarized by either gramicidin or a high potassium concentration; and (3) Ca2+ influx was abrogated by cytochrome P450 inhibitors such as lipoxygenase inhibitors or imidazole antimicotic drugs. CD3 mAb and thapsigargin thus triggered the same signaling events, probably involving a cytochrome P450, to transmit information from depleted endoplasmic reticulum to the plasma membrane.


Subject(s)
Calcium/metabolism , Muromonab-CD3/pharmacology , T-Lymphocytes/drug effects , Terpenes/pharmacology , Calcium/pharmacology , Cell Line/drug effects , Cell Membrane Permeability/drug effects , Clotrimazole/pharmacology , Econazole/pharmacology , Humans , Indoles , Indomethacin/pharmacology , Masoprocol/pharmacology , Membrane Potentials/drug effects , T-Lymphocytes/enzymology , T-Lymphocytes/metabolism , Thapsigargin
8.
J Biol Chem ; 268(28): 20812-7, 1993 Oct 05.
Article in English | MEDLINE | ID: mdl-8407910

ABSTRACT

Numerous studies on the molecular basis of the mechanism of action of fatty acids have demonstrated their action in cell signaling and particularly on the regulation of cytosolic Ca2+ concentration. Stimulation of Jurkat T cells with CD3 monoclonal antibody results in an increase of intracellular calcium concentration, [Ca2+]i due both to a release of Ca2+ from intracellular stores and a Ca2+ influx. [Ca2+]i increase represents a dynamic balance between Ca2+ influx and efflux. Fatty acids, either saturated (C14:0), monounsaturated (C16:1), or polyunsaturated, belonging to the C18 and the C20 series induce a marked decrease of CD3-induced [Ca2+]i rise. This property of fatty acid is independent of the position of the carbon-carbon double bond but specific of the cis stereoisomeric form. Fatty acids does not block CD3-induced signals but greatly stimulates the Ca2+ extrusion process probably by activating the plasma membrane Ca(2+)-ATPase. This was documented by the observation that fatty acids, reduced to the same extent as [Ca2+]i, elicited either with CD3 monoclonal antibody the calcium ionophore ionomycin or the Ca(2+)-ATPase inhibitor thapsigargin.


Subject(s)
Antibodies, Monoclonal/physiology , CD3 Complex/metabolism , Calcium/metabolism , Fatty Acids/pharmacology , Signal Transduction/drug effects , T-Lymphocytes/drug effects , Calcium-Transporting ATPases/antagonists & inhibitors , Cell Line , Humans , Ionomycin/pharmacology , Lymphocyte Activation , Phosphatidylserines/biosynthesis , T-Lymphocytes/metabolism , Terpenes/pharmacology , Thapsigargin
9.
Cell Signal ; 5(5): 623-31, 1993 Sep.
Article in English | MEDLINE | ID: mdl-7508733

ABSTRACT

In this report, it is shown that the platelet-activating factor (PAF) induced, in human B lymphoblastoid cells, 86Rb+ influx and efflux suggesting that it activated a K+ channel. Opening of this channel was dependent on PAF-induced Ca2+ mobilization. Ionomycin and thapsigargin--a specific inhibitor of (Ca(2+)-Mg2+)-ATPase--mimicked the effect of PAF both on intracellular calcium and activation of the channel. This channel was inhibited by charybdotoxin, high doses of tetraethylammonium and barium but was insensitive to apamin, 4-aminopyridine. These features indicate that PAF activated a Ca(2+)-dependent K+ channel. In these cells, PAF also induced the expression of c-fos oncogene. This effect was not affected by charybdotoxin indicating that this channel is not involved in the control of early gene transcription.


Subject(s)
Calcium/metabolism , Platelet Activating Factor/pharmacology , Potassium Channels/drug effects , Potassium Channels/metabolism , Apamin/pharmacology , B-Lymphocytes/drug effects , B-Lymphocytes/metabolism , Cell Line, Transformed , Charybdotoxin , Gene Expression/drug effects , Genes, fos , Herpesvirus 4, Human , Humans , Ionomycin/pharmacology , Scorpion Venoms/pharmacology , Signal Transduction
10.
Eur J Immunol ; 23(3): 768-71, 1993 Mar.
Article in English | MEDLINE | ID: mdl-7680616

ABSTRACT

The CD20 molecule is a phosphoprotein expressed on the surface of B lymphocytes that plays a role in the regulation of B cell proliferation and differentiation. In this study it was found that monoclonal antibodies (mAb) directed to CD20 decrease the expression of IgM at the surface of normal human B lymphocytes and B cell lines. This effect was time-dependent with a half-time of about 5 h. Incubation of B cells with CD20 mAb B1 did not affect the steady-state level of IgM mRNA, suggesting that it acts at a nontranscriptional stage. Phorbol esters also produced inhibitory effect on surface IgM expression. Staurosporine reversed both the phorbol ester- and the CD20-induced down-regulation. Genistein did not reverse the down-regulation induced by the CD20 mAb B1. CD20 most likely triggers a protein kinase C-dependent pathway to down-regulate sIgM. CD20 mAb also counteracted the interleukin-4 (IL-4)-induced up-regulation of sIgM. The ability of anti-IgM to mobilize intracellular calcium was reduced in sIgM down-regulated cells, suggesting that B cells activation through the antigen receptor may be negatively regulated by CD20 and positively by IL-4.


Subject(s)
Antigens, CD/immunology , Antigens, Differentiation, B-Lymphocyte/immunology , B-Lymphocytes/metabolism , Immunoglobulin M/metabolism , Receptors, Antigen, B-Cell/metabolism , Alkaloids/pharmacology , Antibodies, Monoclonal , Antigens, CD20 , Down-Regulation , Gene Expression , Genes, Immunoglobulin , Genistein , Humans , Immunoglobulin mu-Chains/genetics , In Vitro Techniques , Interleukin-4/pharmacology , Isoflavones/pharmacology , Protein Kinase Inhibitors , RNA, Messenger/genetics , Staurosporine , Time Factors
11.
Eur J Immunol ; 22(6): 1573-7, 1992 Jun.
Article in English | MEDLINE | ID: mdl-1534760

ABSTRACT

It has been reported that the 45-kDa low-affinity Fc epsilon receptor (Fc epsilon RII) on B cells is cleaved spontaneously from the cell surface to release soluble fragments. This study demonstrates an additional fate of the Fc epsilon RII. 125I-labeled CD23+ B cells were cultured for 24 h at 37 degrees C. After lysis, cell extracts were immunoprecipitated with CD23 monoclonal antibodies. Using this methodology, we demonstrated that an increasing amount of the labeled Fc epsilon RII becomes progressively resistant to externally applied trypsin, indicating that a fraction of the cell surface receptors are internalized. In parallel, a labeled 16-kDa material, recognized by CD23 monoclonal antibodies directed to the lectin-like domain of the Fc epsilon-RII appears inside the cells. Chloroquine does not affect internalization of the Fc epsilon RII, but completely abolishes the formation of the intracellular fragment, suggesting that the receptor is processed by proteolytic cleavage in acidic organelle. In addition, the internalization is enhanced in the presence of CD23 monoclonal antibodies. These data demonstrate that Fc epsilon RII can be internalized by ligand-induced endocytosis and subsequently cleaved in an intracellular compartment. These results also support the view that the Fc epsilon RII is involved in antigen focusing and antigen presentation.


Subject(s)
Antigens, Differentiation, B-Lymphocyte/metabolism , B-Lymphocytes/immunology , Endocytosis/drug effects , Endocytosis/physiology , Receptors, Fc/metabolism , Animals , Antibodies, Monoclonal , B-Lymphocytes/metabolism , Cell Line , Chloroquine/pharmacology , Down-Regulation , Humans , Mice , Precipitin Tests , Receptors, IgE , Time Factors , Trypsin/pharmacology
12.
Immunology ; 73(2): 134-9, 1991 Jun.
Article in English | MEDLINE | ID: mdl-1649123

ABSTRACT

Jurkat T cells, loaded with the fluorescent calcium probe Indo 1, responded to exogenous phosphatidic acid (PA) by transiently increasing their cytosolic Ca2+ concentration. This effect was dose-dependent, remained unmodified when external Ca2+ was chelated with EGTA, and was totally inhibited when cells were first exposed to CD3 monoclonal antibodies, indicating that it was solely due to the release of an intracellular pool, which is also mobilized during a stimulation via the CD3 T-cell receptor (TcR) molecular complex. CD3- and phytohaemagglutinin (PHA)-stimulated Jurkat cells also produced PA, the dose-responses and kinetics of which were consistent with those of calcium release. Moreover, diacylglycerol (DAG) kinase inhibitors abrogated PA production and lowered calcium release by CD3-stimulated cells. PA did not induce any apparent increase in inositol triphosphates (IP3), nor did it modify the increase entailed by activation of the CD3 pathway, pointing out that IP3 can be supplemented in mobilizing calcium from intracellular stores. Conversely, a first exposure to PA only partially inhibited the CD3- or ionomycin-induced internal release of calcium, suggesting either a rapid restoration of the PA-sensitive stores, or a contribution of other mediators, such as IP3, in the CD3 activation pathway.


Subject(s)
Antigens, Differentiation, T-Lymphocyte/immunology , Calcium/metabolism , Phosphatidic Acids/physiology , Receptors, Antigen, T-Cell/immunology , T-Lymphocytes/immunology , Antibodies, Monoclonal/immunology , CD3 Complex , Cell Line , Diacylglycerol Kinase , Humans , Inositol 1,4,5-Trisphosphate/biosynthesis , Leukemia, T-Cell/metabolism , Phosphatidic Acids/biosynthesis , Phosphotransferases/antagonists & inhibitors , Phytohemagglutinins/immunology , Tumor Cells, Cultured/metabolism
13.
J Lipid Mediat ; 3(3): 267-81, 1991.
Article in English | MEDLINE | ID: mdl-1685336

ABSTRACT

Activation of Jurkat T cells with phytohemagglutinin (PHA), CD3 or CD2 monoclonal antibodies (mAbs) results in a marked inhibition of phosphatidylserine (PS) synthesis. Activation of Jurkat T cells with PHA in a Ca(2+)-free medium resulted in an arrest of PS synthesis which was not reversed by the addition of Ca2+. The use of BAPTA to chelate Ca2+ ions released from intracellular stores prevented PHA-induced inhibition of PS synthesis. In addition, it was found that during activation, in the presence of BAPTA, a net Ca2+ influx paralleled an increase in PS synthesis, demonstrating that Ca2+ uptake caused an enhanced PS synthesis rather than an inhibition. The use of a CD2 mAb, D66, able to mobilize exclusively Ca2+ from intracellular stores, resulted in 51% inhibition of PS synthesis. N-Ethylmaleimide (NEM), which inhibits both the release of Ca2+ from internal stores and the influx of Ca2+, totally prevents the inhibition of PS synthesis induced by PHA, anti-CD3 or anti-CD2 mAbs. The presence, in the incubation medium, of either NDGA, TPCK or TPA, three drugs able to markedly inhibit Ca2+ influx without modifying the release of Ca2+ from internal stores, did not modify the inhibition of PS synthesis induced by PHA. Moreover all the drugs known to interact with calmodulin were also found to prevent the PHA-induced inhibition of this phospholipid. Taken together, these results show that the inhibition of PS synthesis induced by T cell activators is regulated by both calmodulin and Ca2+ ions recruited from intracellular compartments.


Subject(s)
Calcium/pharmacology , Phosphatidylserines/biosynthesis , T-Lymphocytes/metabolism , Antibodies, Monoclonal/pharmacology , Antigens, CD/immunology , Antigens, Differentiation, T-Lymphocyte/immunology , CD2 Antigens , CD3 Complex , Calcium/metabolism , Calmodulin/antagonists & inhibitors , Cell Line , Egtazic Acid/analogs & derivatives , Egtazic Acid/pharmacology , Ethylmaleimide/pharmacology , Humans , Kinetics , Phytohemagglutinins/pharmacology , Receptors, Antigen, T-Cell/immunology , Receptors, Immunologic/immunology , T-Lymphocytes/drug effects
14.
Immunopharmacology ; 21(2): 109-19, 1991.
Article in English | MEDLINE | ID: mdl-1908837

ABSTRACT

Pertussis toxin (PT) has previously been shown to affect a wide variety of immune responses and to cause lymphocyte proliferation. We have investigated the biochemical basis for the mitogenic activity of PT by using human peripheral blood lymphocytes. PT was found to induce a rapid rise in cytosolic free calcium concentration and an alkalinization of the cytosol through the Na+/H+ antiporter. The toxin was also found to induce expression of IL-2-receptor on CD3+ cells and to stimulate IL-2 production. PT induced proliferation of both CD4+ and CD8+ T cells in the presence (but not in the absence) of accessory cells. PT also stimulated IL-1 production by monocytes but neither IL-1, IL-6 alone nor a combination of the two lymphokines could replace accessory cells suggesting that cell:cell contact is required. Low doses of PT induced ADP-ribosylation of G proteins but this treatment did not affect significantly PHA-induced [Ca2+]i increase and IL-2-induced DNA synthesis suggesting that the substrates of the ADP-ribosyltransferase activity of PT are not involved in the signalling pathways leading to DNA replication.


Subject(s)
Lymphocyte Activation/drug effects , Pertussis Toxin , T-Lymphocytes/drug effects , Virulence Factors, Bordetella/pharmacology , Adenosine Diphosphate Ribose/metabolism , Calcium/metabolism , Cell Communication , GTP-Binding Proteins/metabolism , Humans , Hydrogen-Ion Concentration , In Vitro Techniques , Interleukin-1/physiology , Interleukin-2/biosynthesis , Monocytes/drug effects , Monocytes/immunology , Receptors, Interleukin-2/drug effects , T-Lymphocytes/immunology , T-Lymphocytes/metabolism
15.
Cell Signal ; 3(5): 453-9, 1991.
Article in English | MEDLINE | ID: mdl-1662064

ABSTRACT

Triggering the CD3/TCR complex of T lymphocytes induces a rapid rise in cytosolic free calcium followed by a slowly declining plateau. The level of this plateau depends on external pH, the more alkalinized media leading to higher values. Neither a pH-dependent binding of mAb, nor a perturbation of internal pH can account for this effect. In a sodium-free medium, or in the presence of dimethylamiloride Ca2+, elevation is accompanied by an acidification of the cells; both of them depend, to the same extent, on external calcium concentration. TPA inhibits CD3-, but not ionomycin-induced Ca2+ and H+ raises, indicating that it acts more probably on Ca2+ influx, rather than on its efflux. These results suggest that intracellular calcium could be regulated by a Ca2+/H+ ATPase which drives H+ in and Ca2+ out. In the presence of external Na+, H+ should return to the medium by the Na+/H+ exchanger.


Subject(s)
Antigens, Differentiation, T-Lymphocyte/metabolism , Calcium/metabolism , Lymphocyte Activation , Receptors, Antigen, T-Cell/metabolism , T-Lymphocytes/metabolism , CD3 Complex , Carrier Proteins/metabolism , Cell Line , Fluorescent Antibody Technique , Humans , Hydrogen-Ion Concentration , Kinetics , Protons , Sodium-Hydrogen Exchangers , T-Lymphocytes/immunology , Tetradecanoylphorbol Acetate/pharmacology
16.
Cell Signal ; 3(1): 25-33, 1991.
Article in English | MEDLINE | ID: mdl-1827986

ABSTRACT

Multiple effects of pertussis toxin (PT) on Jurkat T-cells can be distinguished on the basis of their dose-response and their kinetics. High concentrations of PT deliver to cells an activating signal resulting in a rapid rise in [Ca2+]i followed by IL-2 synthesis. This activation is accompanied (within 2 h) by a down-regulation of the CD3/TCR complex from the cell surface. Cells then become refractory towards stimulation by CD3 mAb or PHA. All these effects, referred to as 'mitogenic effects', present the same dose-response curves with an EC50 of 0.5 micrograms/ml. Short term effects (PT-induced Ca2+ movements, down-regulation of CD3/TCR complex and inhibition of PHA and CD3-induced Ca2+ signal) are observed under conditions where no PT-induced ADP-ribosylation can be detected. In contrast, ADP-ribosylation of the 40,000 alpha-subunit of G-proteins requires a sustained (18 h) incubation of intact cells in the presence of low concentration (EC50 = 0.3 ng/ml) of PT. Dose-response curves for PT-dependent ADP-ribosylation and mitogenic effects are separated by three orders of magnitude. Covalent modification of G-protein has no effect on CD3-induced increase in [Ca2+]i and IL-2 synthesis induced by a combination of phorbol ester and either CD3 mAb, PHA or calcium ionophore. These data indicate that transduction of the mitogenic signal does not involve a PT-sensitive G-protein. Furthermore, inhibition of mitogenic signals following PT treatment results from a PT-induced activation leading to a down-regulation of the CD3/T cell receptor complex.


Subject(s)
GTP-Binding Proteins/physiology , Lymphocyte Activation/physiology , Pertussis Toxin , T-Lymphocytes/immunology , Virulence Factors, Bordetella/pharmacology , Adenosine Diphosphate/metabolism , Antigens, Differentiation, T-Lymphocyte/metabolism , CD3 Complex , Calcium/metabolism , Down-Regulation , GTP-Binding Proteins/drug effects , Interleukin-2/biosynthesis , Kinetics , Receptors, Antigen, T-Cell/metabolism , Ribose/metabolism , Tumor Cells, Cultured
17.
Immunopharmacol Immunotoxicol ; 13(1-2): 73-86, 1991.
Article in English | MEDLINE | ID: mdl-1837558

ABSTRACT

We have studied the effect of pertussis toxin (PT) on in vivo priming of T lymphocytes to insulin. Mice were immunized with bovine insulin in complete Freund's adjuvant and antigen-specific DNA synthesis was measured in lymphoid cell suspensions from lymph nodes and spleens. Insulin-specific response was greatly enhanced both in spleen and lymph nodes if mice were given PT at the time of immunization. Mice given PT presented 3 times more cells in spleen and 4 times less in lymph nodes. However, the major antigen-specific response was still observed in lymph nodes. PT had a strong mitogenic effect in vitro on lymph node cells but a weak effect on spleen cells indicating that the adjuvant activity of PT involves other effects besides the mitogenic activity.


Subject(s)
Insulin/immunology , Pertussis Toxin , T-Lymphocytes, Helper-Inducer/drug effects , Virulence Factors, Bordetella/pharmacology , Adjuvants, Immunologic/pharmacology , Animals , Cell Movement/drug effects , Immunization , Lymphocyte Activation , Mice , Mice, Inbred Strains , Mitogens/pharmacology , T-Lymphocytes/drug effects , T-Lymphocytes/immunology , T-Lymphocytes/physiology , T-Lymphocytes, Helper-Inducer/immunology
18.
Mol Immunol ; 26(3): 293-9, 1989 Mar.
Article in English | MEDLINE | ID: mdl-2649792

ABSTRACT

We used a photoaffinity labeling technique to investigate whether a molecular interaction occurs between antigen and Ia molecules on antigen presenting cells (APC) in the absence of T lymphocytes. M.12.4.1 B lymphoma cells (Iad), which are able to present bovine insulin to Iad lymph node primed T cells, were given radioiodinated bovine insulin derivatized with the photoreactive group (2-nitro-4-azidophenylacetyl) at Lys 29 of the B chain of the insulin molecule. Processing of insulin was allowed by incubating the APC with antigen for increasing periods of time at 37 degrees C or 4 degrees C. The covalent coupling of the processed photoreactive antigen to any neighboring cellular protein was thereafter induced by u.v. irradiation. Immunoprecipitation of membrane proteins by monoclonal antibodies showed that under these conditions, the alpha and beta subunits of the Ia molecules were selectively photolabeled. Labeling was time- and temp-dependent as was the internalization of insulin. The apparent mol. wts of the antigen-Ia molecule complexes were not significantly different from that of native Ia molecules radioiodinated by surface labeling, indicating that only a small fragment of the antigen was covalently coupled to Ia molecules. Similar experiments performed with human B lymphoma cells (526 cells) gave similar results. These observations therefore indicate: (1) that Ia molecules expressed by intact APC are able to bind antigens in the absence of T lymphocyte antigen receptor; and (2) that this association, at least for insulin, requires uptake and a proteolytic fragmentation of the antigen by the APC.


Subject(s)
Antigen-Presenting Cells/metabolism , Histocompatibility Antigens Class II/metabolism , Affinity Labels , Animals , Cell Line , Insulin/metabolism , Receptors, Antigen, T-Cell , T-Lymphocytes , Tumor Cells, Cultured
19.
Biochem J ; 242(2): 403-10, 1987 Mar 01.
Article in English | MEDLINE | ID: mdl-3036089

ABSTRACT

Human HepG2 hepatoma cells express a high number of insulin receptors. Growing cells exhibit 70% of their insulin receptors on the plasma membrane. Moreover, cell-surface insulin receptors form molecular complexes with class I major histocompatibility antigens, as determined by co-immunoprecipitation of the receptors by anti-class I monoclonal antibodies. On exposure to saturating concentrations of insulin, the hormone is rapidly internalized into a Pronase-resistant compartment. Internalization of insulin is accompanied by a rapid (t1/2 = 2-3 min) redistribution of insulin receptors from the cell surface to an intracellular compartment. On removal of insulin from the medium, functional receptors recycle back to the plasma membrane, where they can bind insulin again. With chronic exposure of HepG2 cells to insulin, the initial redistribution of receptors is followed by a slow (t1/2 = 9 h) down-regulation of the receptors. Finally, notwithstanding their interaction at the cell surface, insulin receptors and class I major histocompatibility antigens are internalized at different rates and with independent regulation.


Subject(s)
HLA Antigens/immunology , Receptor, Insulin/metabolism , Carcinoma, Hepatocellular/immunology , Carcinoma, Hepatocellular/metabolism , Cell Line , Chemical Precipitation , Half-Life , Humans , Insulin/metabolism , Liver Neoplasms/immunology , Liver Neoplasms/metabolism , Major Histocompatibility Complex , Receptor, Insulin/immunology
20.
J Immunol ; 137(7): 2293-8, 1986 Oct 01.
Article in English | MEDLINE | ID: mdl-3531328

ABSTRACT

Molecular interactions between insulin receptors and MHC antigens were investigated in human B cells. Two B lymphoblastoid cell lines, IM-9 and 526, chosen for their high insulin binding capacity, were found to express 15,000 and 25,000 insulin receptors per cell, respectively. Insulin receptors were labeled with a 125I-photoreactive insulin analogue, and all other surface proteins by lactoperoxidase-catalyzed radioiodination. Neighbor proteins were cross-linked with a cleavable homobifunctional reagent dithio-bis-(succinimidyl propionate) (DSP) and solubilized before immunoprecipitation by anti-HLA monoclonal antibodies. Gel analysis of the precipitated proteins showed that 90% of insulin receptors precipitable by anti-insulin receptor antibodies were precipitated by anti-class I antibodies (anti-heavy chain and anti-beta 2-microglobulin) after cross-linking with 2 mM DSP. In neither IM-9- nor 526 cells could HLA antigens be precipitated by anti-insulin receptor antibodies, suggesting that the concentration of class I antigens largely exceeds the concentration of insulin receptors at the cell surface. In 526 lymphocytes, class I MHC antigens were also found to adjoin class II antigens, since both molecules could be coprecipitated with anti-HLA A, B, C and with anti-HLA-DR antibodies after chemical cross-linking. Down-regulation of insulin receptors by chronic exposure of IM-9 cells to insulin did not affect the amount of MHC molecules present on the cell surface, and conversely, class I MHC molecules were internalized in 526 cells irrespective of the presence of insulin. These results thus show that insulin receptors and MHC antigens form multimolecular complexes in the plasma membrane of cultured human B cells. These interactions, which do not appear to influence the regulation of these proteins on the cell surface, may be involved in the mechanism of hormone signaling.


Subject(s)
B-Lymphocytes/ultrastructure , HLA Antigens , HLA-D Antigens , Receptor, Insulin/metabolism , Cross-Linking Reagents , Endocytosis , Humans , Immunologic Capping , Major Histocompatibility Complex , beta 2-Microglobulin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL